This Site makes heavy use of JavaScript

Either you have JavaScript disabled or your browser does not support JavaScript.

To work properly, this page requires JavaScript to be enabled. If you can enable it in your browser's preferences, you may have a better experience.

Brigham & Women's Study in NVAF | Pradaxa® (dabigatran etexilate) Skip to main content
  • References:
  • 1. Data on file. Boehringer Ingelheim Pharmaceuticals, Inc.
  • 2. Seeger JD, Bykov K, Bartels DB, et al. Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Thromb Haemost. 2015;114(6):1277-1289.
  • 3. Seeger JD, Bartels DB, Huybrechts K, et al. Poster: Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Presented at the American Heart Association (AHA) Scientific Sessions 2015; November 2015; Orlando, Fl.